Status:
TERMINATED
Objective Evaluation of Postoperative Positioning in Macular Hole Surgery
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Haukeland University Hospital
Trondheim University Hospital
Conditions:
Macular Hole
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The macular hole formation takes place in the centre of the retina. A closure of the macular hole is believed to take place if the central retinal area is kept dry in the postoperative period. Therefo...
Eligibility Criteria
Inclusion
- Primary macular hole
- Duration less than 24 months
- Informed consent
Exclusion
- Secondary macular hole i.e. trauma, excessive myopia (more than 6 dioptres)
- Previous vitreomacular surgery
- Age under 18 years
- Unable to sign
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2017
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT02295943
Start Date
November 1 2014
End Date
November 20 2017
Last Update
June 6 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021
2
Stavanger University Hospital
Stavanger, Norway, 4011
3
University Hospital of North Norway
Tromsø, Norway, 9038
4
Trondheim University Hospital
Trondheim, Norway, 7030